Rationale and study design: A randomized controlled trial of early palliative care in newly diagnosed cancer patients in Addis Ababa, Ethiopia

Eleanor Reid, Ephrem Abathun, Jilcha Diribi, Yoseph Mamo, Peter Hall, Marie Fallon, Tigineh Wondemagegnhu, Liz Grant, Eleanor Reid, Ephrem Abathun, Jilcha Diribi, Yoseph Mamo, Peter Hall, Marie Fallon, Tigineh Wondemagegnhu, Liz Grant

Abstract

Patient-reported outcomes and economic aspects of Palliative Care (PC) provision in low-income countries (LIC) are under-studied. Demonstrating the economic value of PC is key to sustainability and guiding health care policy. Our preliminary data in Ethiopia demonstrated a widespread need for PC, poor access to it, and high out of pocket payments (OOP). We suspect that in this and other LIC, PC may function not only to reduce suffering but also as a poverty reduction strategy.We are conducting a randomized controlled trial of standard Oncology care versus standard Oncology care plus PC in newly diagnosed cancer patients in Addis Ababa. Ninety-seven adults presenting to Oncology Clinic will be randomized in a 1:1 ratio. Subjects receiving PC will meet with a PC provider at time of enrollment and at follow up visits in their homes. All subjects will be assessed via questionnaire at enrollment and follow-up Oncology visits at 8 ± 4 and 12 ± 4 weeks. A cost-consequence analysis will be performed, to include: patient-reported OOP and healthcare utilization, the latter to be assessed through chart adjudication. Outcomes will include change in African Palliative Care Association Palliative Outcome Score, changes in OOP and healthcare utilization.We hypothesize that the cost of home-based PC will be offset by improvements in patient-reported outcomes, decreased OOP and healthcare utilization, rendering PC cost-effective in this LIC. These findings may lead to widespread dissemination of an effective, sustainable and cost-saving public PC delivery strategy that would improve the quality of life and death for millions of people.

Trial registration: Clinicaltrials.gov NCT03712436.

Keywords: Cost consequence analysis; Low income country; Palliative care.

Conflict of interest statement

All authors declare that they have no conflict of interest.

© 2020 The Authors.

Figures

Fig. 1
Fig. 1
Study flow.
Fig. 2
Fig. 2
Subject process.

References

    1. Collaborators Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053) 1603-q1`58.
    1. World Health Organization Palliative care factsheet. Available at: Accessed 11 April 2019.
    1. Knaul F.M., Farmer P.E., Krakauer El. Alleviating the access abyss in palliative care and pain relief—an imperative of universal health coverage: the Lancet Commission report. Lancet. 2017 (published online Oct 11.)
    1. World Health Organization Global atlas of palliative care at the end of life. Available at: Downloaded 1/28/2016.
    1. Krakauer E et al. Palliative care and pain control. In: jamison, dean T.; gelband, hellen; horton, susan; jha, prabhat; laxminarayan, ramanan; mock, charles N.; nugent, rachel. 2017. Disease Control Priorities, third ed. : Volume 9. Improving Health and Reducing Poverty. Washington, DC: World Bank. © World Bank. License: CC BY 3.0 IGO.
    1. WHO . WHO; 2013. Making Fair Choices on the Path to Universal Health Coverage. Final Report of the WHO Consultative Group on Equity and Universal Health Coverage.
    1. World Health Organization Cost-effectiveness and strategic planning (WHO-CHOICE) Accessed 11 April 2019.
    1. Boerma T., Eozenou P., Evans D. Monitoring progress towards universal health coverage at country and global levels. PLoS Med. 2014;11
    1. Li Y., Wu Q., Xu L. Factors affecting catastrophic health expenditure and impoverishment from medical expenses in China: policy implications of universal health insurance. Bull. World Health Organ. 2012;90:664–671.
    1. World Health Organization WHO estimates cost of reaching global health targets by 2030. Accessed 11 April 2019.
    1. Huffman M.D., Rao K.D., Pichon-Riviere A. A cross-sectional study of the microeconomic impact of cardiovascular disease hospitalization in four low- and middle-income countries. PLoS One. 2011;6
    1. Xu K., Evans D.B., Kawabata K. Household catastrophic health expenditure: a multicountry analysis. Lancet. 2003;362:111–117.
    1. Reid E., Ayers N., Gudina E., Wondimamegegnu D., Mamo Y. Caring for life-limiting illness in Ethiopia: a mixed-methods assessment of outpatient palliative care needs. J. Palliat. Med. 2018 Feb 9
    1. Anderson R.E., Grant L. What is the value of palliative care provision in low-resource settings? BMJ Global Health. 2017;2
    1. Reid E., Kovalerchik O., Jubanyik K., Brown S., Grant L. Is palliative care cost-effective in low-income and middle-income countries? A mixed-methods systematic review. British Medical Journal Supportive and Palliative Care. 2018:1–10. 0.
    1. Smith S., Brick B., O'Hara S., Normand C. Evidence on the cost and cost-effectiveness of palliative care: a literature review. Palliat. Med. 2014;28(2):130–150.
    1. Anderson R.E., Grant L. What is the value of palliative care provision in low-resource settings? BMJ Global Health. 2017;2
    1. Harding R. Validation of a core outcome measure for palliative care in Africa: the APCA african palliative outcome Scale. Health Qual. Life Outcome. 2010 Jan 25;8:10.
    1. Emanuel L.L., Alpert H.R., Emanuel E.E. Concise screening questions for clinical assessments of terminal care: the needs near the end-of-life care screening tool. J. Palliat. Med. 2001;4:465–474.
    1. Drummond M., Sculpher M., Torrance G., O'Brien B., Stoddart G. Oxford, Oxford University Press; 2005. Methods for the Economic Evaluation of Health Care Programmes.
    1. Brazier J., Ratcliffe J., Salomon J., Tsuchiya A. Oxford, Oxford University Press; 2007. Measuring and Valuing Health Benefits for Economic Evaluation.
    1. World Bank Ethiopia country profile. 2016. Accessed 11 April 2019.
    1. Federal Democratic Republic of Ethiopia MoH. Ethiopia's Fifth National Health Accounts. Addis Ababa Ethiopia; 2014. 2010/2011.
    1. Go Sarcopenia and inflammation are independent predictors of survival in male patients newly diagnosed with small cell lung cancer. Support. Care Canc. 2016;24:2075–2084.
    1. Kiriu T., Yamamoto M., Nagano T., Hazama D., Sekiya R., Katsurada M. The timeseries behavior of neutrophil-to-lymphocyte ratio is useful as a predictive marker in non-small cell lung cancer. PloS One. 2018;13(2)
    1. Ramsey S.D., Willke R.J., Glick H., Reed S.D., Augustovski F., Jonsson B., Briggs A., Sullivan S.D. Cost-effectiveness analysis alongside clinical trials II-an ISPOR good research practices task force report. Value Health. 2015;18(2):161–172.
    1. Godlee F. Publishing study protocols: making them visible will improve registration, reporting and recruitment. BMC News Views. 2001;2:4.
    1. May P., Normand C., Cassel J.B. Economics of palliative care for hospitalized adults with serious illness: a meta-analysis. JAMA Intern Med. 2018;178:820–829.
    1. Kelley A.S., Deb P., Du Q. Hospice enrollment saves money for Medicare and improves care quality across a number of different lengths-of-stay. Health Aff. 2013;32:552–561.
    1. Obermeyer Z., Makar M., Abujaber S. Association between the medicare hospice benefit and health care utilization and costs for patients with poor-prognosis cancer. J. Am. Med. Assoc. 2014;312:1888–1896.
    1. Smith T.J., Cassel J.B. Cost and non-clinical outcomes of palliative care. J. Pain Symptom Manag. 2009;38:32–44.
    1. Pyenson B., Connor S., Fitch K. Medicare cost in matched hospice and non-hospice cohorts. J. Pain Symptom Manag. 2004;28:200–210.
    1. Felder S., Meier M., Schmitt H. Health care expenditure in the last months of life. J. Health Econ. 2000;19:679–695.
    1. Zimmermann C., Riechelmann R., Krzyzanowska M. Effectiveness of specialized palliative care: a systematic review. J. Am. Med. Assoc. 2008;299:1698–1709.
    1. Ramsey S., Willke R., Briggs A., Brown R., Buxton M., Chawla A., Cook J., Glick H., Liljas B., Petitti D. Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA task force report. Value Health. 2005;8(5):521–533.
    1. O'Sullivan A.K., Thompson D., Drummond M.F. Collection of health-economic data alongside clinical trials: is there a future for piggyback evaluations? Value Health. 2005;8(1):67–79.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera